1 / 9

Allergic Rhinitis Market

Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the immune system overreacts to allergens in the air. Signs and symptoms include a runny or stuffy nose, sneezing, red, itchy, and watery eyes, and swelling around the eyes.<br>

DelveInsight
Download Presentation

Allergic Rhinitis Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Allergic Rhinitis Market insight, Epidemiology and Market forecast 2027

  2. Allergic Rhinitis Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the immune system overreacts to allergens in the air. Signs and symptoms include a runny or stuffy nose, sneezing, red, itchy, and watery eyes, and swelling around the eyes.

  3. Allergic rhinitis Allergy and immunology Specialty Stuffy nose, sneezing, red, itchy and watery eyes, swelling around the eyes Symptoms Genetic and environmental factors Causes Frequency ~20% ( Western countries )

  4. Classification 01 Allergic rhinitis may be seasonal or perennial. 02 Seasonal allergic rhinitis occurs in particular during pollen seasons. It does not usually develop until after 6 years of age. 03 Perennial allergic rhinitis occurs throughout the year. This type of allergic rhinitis is commonly seen in younger children. It may also be classified as Mild-Intermittent, Moderate-Severe intermittent, Mild-Persistent, and Moderate-Severe Persistent. 04

  5. Market Insights Pharmacotherapy and immunotherapy are recommended for treating Allergic Rhinitis Targeted immunotherapy is effective in changing the natural course of Allergic Rhinitis. Launch of therapies such as Omalizumab (Novartis Pharmaceuticals) and GSP 301 (Glenmark Pharma) shall fuel the growth of the market. Market size of allergic rhinitis in the US was found to be xxx in 2016. The market size of allergic rhinitis shall increase at a CAGR of XX% during forecast period (2018-2027)

  6. Emerging Therapy Analysis Omalizumab GSP 301 Launch of emerging therapies such as Omalizumab (Novartis Pharmaceuticals) GSP 301 (Glenmark Pharmaceuticals Ltd) And other effective therapies, are expected to change the treatment landscape of Allergic Rhinitis in upcoming years.

  7. COMPLETE INFORMATION For complete information please click the link below CLICK HERE Or write us at info@delveinsight.com

  8. ABOUT DELVEINSIGHT ABOUT DELVEINSIGHT Insight across value chain to help organization make important business decision through the use and analysis of actionable market intelligence. • Delveinsight , market research & consulting firm provides end to end comprehensive solutions to the life science industry. • We help our customers in best decision-making through our expertise in research & analysis & comes out with unmatched data & forecasts. MISSION • To be the most trusted market research & business consulting firm worldwide. • To be the renowned & premier data driven solutions providers among pharma & biotech companies. VISION

More Related